Adaptive sampling explained: the future of flexible target enrichment
)
Join us for a deep dive into adaptive sampling, a unique software-based target enrichment method from Oxford Nanopore Technologies.
This knowledge exchange will cover the fundamentals of adaptive sampling — what it is, how it works, and where it excels.
We will also share best-practice insights into workflows and real-world case studies highlighting how researchers are leveraging adaptive sampling across a growing suite of applications, from pharmacogenomics to hereditary cancer.
Join us on Tuesday, 23 September at 4pm BST (11am EST).
Miguel Reis (Adaptive Sampling Lead) will present an in-depth look at the technical foundations of adaptive sampling, explaining how the technology works and what makes it unique. He will explore its core mechanisms and highlight how these enable powerful, flexible applications across a range of research areas.
Ellie Juarez (Associate Director, Segment Marketing – Oncology) will introduce how adaptive sampling delivers fast, rich insights through flexible, easily customisable workflows. She will highlight key applications and products leveraging this technology to provide rapid answers and novel insights across oncology and beyond.
In this webinar, participants will learn:
How adaptive sampling works
How adaptive sampling can be applied for targeted approaches in hereditary cancer, pharmacogenomics (PGx), and central nervous system (CNS) tumour profiling
How flexible and streamlined adaptive sampling workflows reduce hands-on time while accelerating results
Meet the speakers
)
Ellie Juarez, Associate Director, Segment Marketing – Oncology, Oxford Nanopore TechnologiesEleonora (Ellie) Juarez is currently the market segment manager for Oncology at Oxford Nanopore Technologies. With her extensive cancer genomics experience and a doctorate in molecular and medical genetics, she drives the development of new oncology assays, enabling cancer researchers to answer the most complex biological questions using nanopore sequencing. Juarez has held leadership roles at Twinstrand Biosciences, Integrated DNA Technologies (IDT), and Twist Bioscience, where she significantly contributed to product and application development and corporate strategy.
)
Miguel Reis, Development Scientist, Oxford Nanopore TechnologiesMiguel Reis is a biotechnology researcher who has worked in various research institutions in three continents. He is currently a development scientist at Oxford Nanopore Technologies, leading the Adaptive Sampling and Run Until features development.
